🚀 Accelerating Drug Discovery with Pharmidex In Silico Expertise, the complete Video! 🧬🔬
March 3, 2025

At Pharmidex, we harness cutting-edge computational tools to fast-track drug discovery.


Our 5-Step In Silico Drug Discovery Process

🔹 1. Target Structure Determination – High-resolution X-ray, Cryo-EM & homology modeling

🔹 2. Ligand Identification – Virtual screening, de novo design & library mining

🔹 3. Active/Binding Site Analysis – Molecular dynamics & protein flexibility studies

🔹 4. Molecular Docking & Pharmacophore Modeling – Gold-standard binding affinity predictions

🔹 5. Validation & Optimization – Target validation & pathway analysis


💡 Need to discover a drug for your target?

💡 Have drug candidates and need to identify their target?


With expert computational, structural, and molecular biology insights, we provide:

✅ Advanced hit & binding site identification

✅ 2D & 3D ligand-based design

✅ Molecular dynamics & target validation


📩 Let’s collaborate and drive innovation forward!


#Pharmidex #DrugDiscovery #InSilico #Biotech #AIinDrugDiscovery #PharmaInnovation

February 4, 2026
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis
February 2, 2026
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry
January 29, 2026
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
More Posts